Dr. Winer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 Park Street
New Haven, CT 06510Phone+1 617-632-6876Fax+1 617-632-1930
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1989
Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987- Yale-New Haven Medical CenterInternship, Internal Medicine, 1983 - 1984
Yale School of MedicineClass of 1983
Certifications & Licensure
ME State Medical License Current
CT State Medical License 2021 - 2025
MA State Medical License 1997 - 2023
NC State Medical License 1987 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases Start of enrollment: 2004 Oct 01
- Educational Interventions for Patients With DCIS Start of enrollment: 2003 May 01
- Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.Johanna Klughammer, Daniel L Abravanel, Åsa Segerstolpe, Timothy R Blosser, Yury Goltsev
Nature Medicine. 2024-11-01 - A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer.Antonio Giordano, Priya U Kumthekar, Qingchun Jin, Busem Binboga Kurt, Siyang Ren
Clinical Cancer Research. 2024-11-01 - 2 citationsAdjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Corre...Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau Dang, Denise A Yardley
Journal of Clinical Oncology. 2024-11-01
Journal Articles
- Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast CancerEric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
- Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast CancerSara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
- Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 StudyM C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
- Join now to see all
Lectures
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/11/2013
- 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS)UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/12/2012
Press Mentions
Special Session Explores Considerations Behind Breast Cancer Drug Approvals, TrialsDecember 15th, 2024- Cancer Dietitian Reveals Two Things She Tells People to Avoid ConsumingDecember 14th, 2024
- Dr. William K. Oh Appointed Medical Director of Smilow Cancer Hospital at Greenwich and Director of Precision Medicine at Yale Cancer CenterDecember 6th, 2024
- Join now to see all
Grant Support
- Clinical Studies CoreNational Cancer Institute2008–2009
- Cancer And Leukemia Group BNational Cancer Institute2006–2008
- C-2: Clinical Study CoreNational Cancer Institute2005–2007
- Psychosocial Outcomes/Health Behaviors: Women With DCISNational Cancer Institute2000–2002
- Tailored Information Materials About BRCA1 TestingNational Cancer Institute1995–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
